Though it faces new legal challenges, mifepristone may offer yet more
By Elisa Wells
Sept. 28, 2025
When the Food and Drug Administration approved mifepristone, the abortion pill, on Sept. 28, 2000, none of us working on expanding access to reproductive health care could have imagined the future we find ourselves in 25 years later. From the fall of Roe in 2022 and the subsequent banning or restriction of abortion in 19 states, to South Carolina’s recent efforts to include some forms of birth control in its total abortion ban, access to the basic medical care and medications that allow us to control our reproductive destinies is hanging by a thread. In the midst of this reproductive health care apocalypse, mifepristone is proving itself to be a hero in the fight for abortion access.
Continued: https://www.statnews.com/2025/09/28/mifepristone-abortion-pill-fda-approval-25th-anniversary/